PECTOLYN EXPECTORANT 4.05 g/150ml, 0.033 g/150ml, 0.42 g/150ml, 1.9485 g/150ml Јордан - Енглески - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

pectolyn expectorant 4.05 g/150ml, 0.033 g/150ml, 0.42 g/150ml, 1.9485 g/150ml

شركة دار الدواء للتنمية والأستثمار - dar al dawa development and investment co ltd - ammonium chloride 4.05 g/150ml, menthol 0.033 g/150ml, diphenhydramine hcl 0.42 g/150ml, tribasic sod.citrate,2h2o 1.9485 g/150ml - 4.05 g/150ml, 0.033 g/150ml, 0.42 g/150ml, 1.9485 g/150ml

Omnipaque 350 113.25g/150mL Injection Bottle Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

omnipaque 350 113.25g/150ml injection bottle

ge healthcare australia pty ltd - iohexol, quantity: 755 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium hydroxide; water for injections; hydrochloric acid; sodium calcium edetate - indications as at 12 november 2003: intravascular: omnipaque is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. in children, omnipaque is indicated for angiography and urography. oral/body cavities: omnipaque is indicated in adults for arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.

HERBIFIT POLAR GEL 150ml Combination Уједињени Арапски Емирати - Енглески - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

herbifit polar gel 150ml combination

starlink drug store l.l.c bosnia and herzegovina - 150ml plastic tube - gel - combination - musculoskeletal ,joint diseases-soft-tissue inflammation

VISIPAQUE iodixanol 82.5g/150mL (550mg/mL) injection bag Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 82.5g/150ml (550mg/ml) injection bag

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; calcium chloride dihydrate; trometamol; water for injections; sodium calcium edetate - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 82.5g/150mL (550mg/mL) injection bottle Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 82.5g/150ml (550mg/ml) injection bottle

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; calcium chloride dihydrate; trometamol; water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 97.8g/150mL (652mg/mL) injection bag Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 97.8g/150ml (652mg/ml) injection bag

ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; sodium chloride; calcium chloride dihydrate; water for injections; trometamol; sodium hydroxide; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 97.8g/150mL (652mg/mL) injection bottle Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 97.8g/150ml (652mg/ml) injection bottle

ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: water for injections; sodium calcium edetate; trometamol; calcium chloride dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid - visipaque is indicated, in adult patients, for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa).